A Study on Regulating OSCC Cell Function by Blocking Integrin αvβ3 With Cilengitide
Journal of Oral Pathology & Medicine · 2025
DOI: 10.1111/jop.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2025. Verfasst von Liujun Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Centre of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Integrin alphaVbeta3, Carcinoma, Squamous Cell, Mouth Neoplasms, Snake Venoms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: The National Natural Science Foundation, The Natural Science Foundation of Hunan Province, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Background
Oral squamous cell carcinoma (OSCC) is the most important histologic type of oral tumor. Integrin‐ and integrin‐dependent processes are involved in almost every step of cancer progression. Integrin αvβ3 was initially considered an integrin associated with tumor angiogenesis. With the gradual deepening of research, it was found that αvβ3 also plays a role in tumor cells. This study aimed to explore the function of tumor cell integrin αvβ3 in the progression of OSCC.
Methods
Immunohistochemical methods in OSCC tissues explored the expression of integrin αvβ3. CCK‐8, EdU, Cell cycle assay, Scratch test, Transwell, Cell adhesion assay, Colony formation assay, Apoptosis assay, and in vivo experiment were performed to investigate the effects of integrin αvβ3 on the biological behaviors of OSCC cells such as proliferation, adhesion, migration, and invasion.
Results
In this study, we found that integrin αvβ3 expression was upregulated in OSCC. The inhibition of integrin αvβ3 expression by cilengitide resulted in the inhibition of proliferation, adhesion, migration, and invasion of OSCC cells.
Conclusion
Integrin αvβ3 regulates cell proliferation by affecting the cell cycle. Furthermore, inhibition of integrin αvβ3 expression significantly suppresses migration and invasion of OSCC cells in vitro and in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Centre of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Research Center of Oral and Maxillofacial Tumor, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, China.
ORCID-Profile: Liujun Zeng, Tong Su
Förderung
- The National Natural Science Foundation
- The Natural Science Foundation of Hunan Province
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zeng, L., Nie, H., Xiong, H., Yang, Z., Hu, X., & Su, T. (2025). A Study on Regulating OSCC Cell Function by Blocking Integrin αvβ3 With Cilengitide. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.70004
Vancouver
Zeng L, Nie H, Xiong H, Yang Z, Hu X, Su T. A Study on Regulating OSCC Cell Function by Blocking Integrin αvβ3 With Cilengitide. Journal of Oral Pathology & Medicine. 2025. doi:10.1111/jop.70004
BibTeX
@article{Zeng2025,
author = {Zeng, Liujun and Nie, Huanquan and Xiong, Haofeng and Yang, Zhimin and Hu, Xin and Su, Tong},
title = {A Study on Regulating OSCC Cell Function by Blocking Integrin αvβ3 With Cilengitide},
journal = {Journal of Oral Pathology & Medicine},
year = {2025},
doi = {10.1111/jop.70004}
}
EUVIMED